Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS)
Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
The primary study objective is to demonstrate the clinical effectiveness of SERETIDE therapy
compared to the current care in management of moderate to severe persistent asthma patients
in Korea.
Phase:
Phase 4
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Salmeterol Xinafoate Xhance